Skip to main content
. 2021 Sep 27;20:15330338211041253. doi: 10.1177/15330338211041253

Figure 5.

Figure 5.

ICAT may inhibit Wnt signaling pathway by binding to β-catenin in CRC. (A) Co-IP and immunofluorescence detection of ICAT and β-catenin binding in stable overexpression SW480 cells. (B) Co-IP and immunofluorescence detection of ICAT and β-catenin binding in stable overexpression DLD1 cells.

Abbreviations: ICAT, inhibitor of β-catenin and T-cell factor; CRC, colorectal cancer; co-IP, co-immunoprecipitation.